Fibrocell Science, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 43 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-11-23: Reporting owner Selzer Kenneth A; Form 4; Security Non-Qualified Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-07-18: Reporting owner Greenspan Todd James; Form 4; Security Employee Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-06-13: Reporting owner CIALLELLA SUSAN STRANAHAN; Form 4; Security Employee Stock Option (Right to Buy); Transaction Holding.
- 2007-06-13: Reporting owner CIALLELLA SUSAN STRANAHAN; Form 4; Security Employee Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-11-23 | Selzer Kenneth A Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.14 exercise price | 2007-11-27 | |
| 2007-07-18 | Greenspan Todd James Officer (Corporate Controller) | 4 | Employee Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 135,000 owned after | $3.38 exercise price | 2007-07-20 | |
| 2007-06-13 holding as of filing | CIALLELLA SUSAN STRANAHAN Other (Former Director and Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | 160,000 owned after | $1.89 exercise price | 2007-06-13 | |
| 2007-06-13 holding as of filing | CIALLELLA SUSAN STRANAHAN Other (Former Director and Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | 460,000 owned after | $4.70 exercise price | 2007-06-13 | |
| 2007-06-13 holding as of filing | CIALLELLA SUSAN STRANAHAN Other (Former Director and Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | 760,000 owned after | $1.88 exercise price | 2007-06-13 | |
| 2007-02-14 holding as of filing | Trider Steven Officer (Senior VP - Americas) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 200,000 owned after | $1.87 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | Greenspan Todd James Officer (Corporate Controller) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 50,000 owned after | $4.45 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | Greenspan Todd James Officer (Corporate Controller) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 80,000 owned after | $1.89 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | CIALLELLA SUSAN STRANAHAN Director, Officer (President, Exec. VP & Sec.) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 300,000 owned after | $4.70 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | CIALLELLA SUSAN STRANAHAN Director, Officer (President, Exec. VP & Sec.) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 460,000 owned after | $1.89 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | CIALLELLA SUSAN STRANAHAN Director, Officer (President, Exec. VP & Sec.) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 860,000 owned after | $1.88 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | TETI NICHOLAS Director, Officer (Cheif Executive Officer) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 2,000,000 owned after | $1.88 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | TETI NICHOLAS Director, Officer (Cheif Executive Officer) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 2,500,000 owned after | $1.88 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | DALY DECLAN Officer (CFO & Exec. VP - Europe) | 5 | Employee Stock Option (Right to buy) Derivative · Direct | Holding | 325,000 owned after | $1.87 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | WEBB MARSHALL G Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 30,000 owned after | $9.00 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | WEBB MARSHALL G Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 50,000 owned after | $7.67 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | WEBB MARSHALL G Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 80,000 owned after | $2.14 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | WEBB MARSHALL G Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 96,667 owned after | $3.76 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | TOH HENRY Y L Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 100,000 owned after | $6.00 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | TOH HENRY Y L Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 120,000 owned after | $7.67 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | TOH HENRY Y L Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 150,000 owned after | $2.14 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | TOH HENRY Y L Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 166,667 owned after | $3.76 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | MORRELL STEVEN Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 100,000 owned after | $6.00 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | MORRELL STEVEN Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 200,000 owned after | $6.00 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | MORRELL STEVEN Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 220,000 owned after | $7.67 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | MORRELL STEVEN Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 250,000 owned after | $2.14 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | MORRELL STEVEN Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 266,667 owned after | $3.76 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | DEMARTINO RALPH V Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 100,000 owned after | $6.00 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | DEMARTINO RALPH V Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 200,000 owned after | $6.00 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | DEMARTINO RALPH V Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 220,000 owned after | $7.67 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | DEMARTINO RALPH V Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 250,000 owned after | $2.14 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | DEMARTINO RALPH V Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 275,000 owned after | $3.76 exercise price | 2007-02-14 | |
| 2007-02-14 holding as of filing | VANDEWARKER TERRY E Director | 5 | Non-Qualified Stock Option Derivative · Direct | Holding | 30,000 owned after | $3.47 exercise price | 2007-02-14 | |
| 2007-02-06 | Calman Sandra Officer (Chief Medical Officer & V.P.) | 4/A | Employee Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $3.10 exercise price | 2007-04-30 | |
| 2007-02-06 | Calman Sandra Officer (Chief Medical Officer & V.P.) | 4/A | Employee Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 200,000 owned after | $3.10 exercise price | 2007-04-30 | |
| 2007-02-06 | Calman Sandra Officer (Chief Medical Officer & V.P.) | 4 | Employee Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $3.10 exercise price | 2007-02-12 | |
| 2007-01-30 | Greenspan Todd James Officer (Corporate Controller) | 4 | Employee Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 85,000 owned after | $2.73 exercise price | 2007-02-01 | |
| 2007-01-30 | DALY DECLAN Officer (CFO & Exec. VP-Europe) | 4 | Employee Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 355,000 owned after | $2.73 exercise price | 2007-02-01 | |
| 2007-01-24 | VANDEWARKER TERRY E Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 60,000 owned after | $2.37 exercise price | 2007-01-26 | |
| 2007-01-24 | MORRELL STEVEN Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 296,666 owned after | $2.37 exercise price | 2007-01-26 | |
| 2007-01-24 | WEBB MARSHALL G Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 126,667 owned after | $2.37 exercise price | 2007-01-26 | |
| 2007-01-24 | DEMARTINO RALPH V Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 305,000 owned after | $2.37 exercise price | 2007-01-26 | |
| 2007-01-24 | TOH HENRY Y L Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 196,667 owned after | $2.37 exercise price | 2007-01-26 |